当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析

济川药业

(600566)

  

流通市值:372.16亿  总市值:374.62亿
流通股本:9.16亿   总股本:9.22亿

济川药业(600566)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润8.47亿元,每股收益0.92元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益1421540.92万元,未分配利润969304.25万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产1936140.54万元,负债514599.61万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入2,402,545,954.329,654,537,192.676,536,764,954.984,628,976,049.33
营业总成本1,594,276,317.546,516,457,726.294,458,429,019.853,213,238,134.65
营业利润885,925,169.463,258,135,771.82,224,683,531.191,532,181,652.35
利润总额989,790,164.223,297,089,590.22,259,575,656.871,562,466,615.2
净利润846,787,304.112,827,062,991.251,947,379,873.641,342,057,774.06
其他综合收益----
综合收益总额846,787,304.112,827,062,991.251,947,379,873.641,342,057,774.06
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计15,497,144,274.9314,235,429,851.5712,779,125,973.1112,601,951,320.32
非流动资产合计3,864,261,093.233,908,264,726.953,821,528,590.643,785,461,092.99
资产总计19,361,405,368.1618,143,694,578.5216,600,654,563.7516,387,412,413.31
流动负债合计4,961,751,163.64,591,861,830.433,905,300,438.034,281,858,035.4
非流动负债合计184,244,965.97182,970,240.43211,433,853.52210,142,002.55
负债合计5,145,996,129.574,774,832,070.864,116,734,291.554,492,000,037.95
归属于母公司股东权益合计14,194,467,077.8913,349,441,189.4112,465,558,820.611,878,059,010.08
股东权益合计14,215,409,238.5913,368,862,507.6612,483,920,272.211,895,412,375.36
负债和股东权益合计19,361,405,368.1618,143,694,578.5216,600,654,563.7516,387,412,413.31
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计3,706,314,397.211,205,969,408.58,683,452,611.326,214,960,820.95
经营活动现金流出小计2,367,511,844.137,742,010,772.675,823,813,469.244,016,430,284.74
经营活动产生的现金流量净额1,338,802,553.073,463,958,635.832,859,639,142.082,198,530,536.21
投资活动现金流入小计2,118,896,311.814,743,416,960.594,040,790,940.262,690,191,954.26
投资活动现金流出小计455,347,903.795,137,644,623.93,634,261,467.621,307,649,861.81
投资活动产生的现金流量净额1,663,548,408.02-394,227,663.31406,529,472.641,382,542,092.45
筹资活动现金流入小计667,379,039.431,109,641,517.49606,496,858.78361,190,307.08
筹资活动现金流出小计15,633,131.221,260,330,526.821,015,577,772.66517,658,228.97
筹资活动产生的现金流量净额651,745,908.21-150,689,009.33-409,080,913.88-156,467,921.89
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额3,654,096,869.32,919,041,963.192,857,087,700.843,424,604,706.77
期末现金及现金等价物余额11,392,079,679.387,737,982,810.087,676,028,547.738,243,545,553.66
最新报告期:2024-04-22
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
财通证券张文录3.373.804.222024-04-22
兴业证券孙媛媛3.273.694.122024-04-21
国泰君安丁丹3.283.583.932024-04-21
中泰证券孙宇瑶,祝嘉琦3.383.724.052024-04-21
浙商证券孙建3.343.914.562024-04-19
TOP↑